CASE Op-Ed – Issues & Insights: Opening Up Mid-Band Spectrum Is Key For America To Win 5G Race
Gerard Scimeca – Co-founder, CASE December 4, 2020 he COVID-19 public health crisis caused millions of Americans to lose...
Gerard Scimeca – Co-founder, CASE December 4, 2020 he COVID-19 public health crisis caused millions of Americans to lose...
Gerard Scimeca – CASE October 7, 2020 This month a seminar hosted by RealClear Politics sounded yet another alarm regarding America’s highly...
Gerard Scimeca – Chairman CASE July 24, 2020 As U.S. farmers and ranchers struggle to maintain their footing during...
Matthew Kandrach – President, CASE June 18, 2020 After the Arab oil embargo in 1973, the United States responded by...
Gerard Scimeca – Chairman, CASE April 23, 2020 An empty grocery shelf focuses the mind like nothing else. With COVID-19...
December 18, 2019 The government’s current review of the proposed merger between defense contractor Raytheon and United Technologies (UT) may not...
Matthew Kandrach – President, CASE October 11, 2019 The element cobalt isn’t something most people think of every day. And...
Gerard Scimeca – Chairman, CASE June 13, 2019 As President Trump’s trade talks with our major partners sway back...
Matthew Kandrach – President, CASE June 11, 2019 With America’s reliance on imported minerals rising rapidly, the last thing we...
June 5, 2019 CASE today praised the Trump administration and Department of the Interior Secretary David Bernhardt for the release...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers